Abstract
Background. Breast cancer is the most common female cancer worldwide. It is a heterogeneous disease with regard to biological behaviour, responses to treatment and prognosis. The term “triple negative breast cancer” (TNBC), namely, refers to the immunohistochemical classification of breast tumours lacking ER, PgR, and HER2 protein expression. TNBC does not respond to endocrine therapy and chemotherapy remains the main systemic therapeutic option in the adjuvant and metastatic setting of TNBC.
The aim of this study was a retrospective analysis of the results of combined treatment for TNBC.
Patient and methods. In our retrospective analysis, we analized 431 patients with TNBC treated with combination therapy from March 2005 until December 2009 at the Institute of Oncology, Vilnius University. 52.20% of the whole group of patients were women older than 50 years. Stage I was diagnosed in 23.9%, stage II in 49.65%, stage III in 22.74%, stage IV in 3.71% of cases. According to pathological types of the tumour ductal invasive carcinoma was diagnosed in 376 patients (87.24%) and tumour grade G3 was determined in 330 patients (76.57%). All 431 patients underwent surgical treatment, 239 patients had chemotherapy (55.45%). The disease-free survival and overall survival were estimated by the Kaplan-Meier method. The Log-rank test was used for survival comparison between the groups. P < 0.05 indicated a significant statistical difference. All statistical analyses were performed using Stata Statistical Software Version 11.0.
Results. Five-year overall survival for the whole group of patients was 60.0% (95% CI 54.56–64.96); 5-year overall survival for stage I was 81.92% (95% CI 71.38–88.88); 5-year overall survival for stage II was 66.35% (95% CI 58.46–73.09); 5-year overall survival for stage III was 33.99% (95% CI 23.93–44.29), p < 0.00001; five-year disease free survival for the whole group of patients was 56.1% (95% CI 50.18–61.6).
Conclusions. Five-year survival was significantly higher in earlier stages of the disease (81.9%, 66.5%, 34.0% for stages I, II and III), p < 0.00001. Different results for the TNBC patient survival can be explained by biologically distinct subtypes of TNBC.
Downloads
Download data is not yet available.
Most read articles by the same author(s)
-
Agnė Ulytė,
Albertas Ulys,
Kęstutis Sužiedėlis,
Aušvydas Patašius,
Giedrė Smailytė,
Testicular cancer in two brothers of a quadruplet: a case report and a review of literature
,
Acta medica Lituanica: Vol. 24 No. 1 (2017)
-
Laima BLOZNELYTĖ-PLĖŠNIENĖ,
Aleksandras MORDAS,
Vytautas ČEPULIS,
Jonas VENIUS,
Jurgita LIUTKEVIČIŪTĖ-NAVICKIENĖ,
Laimutė RUTKOVSKIENĖ,
Valerijus OSTAPENKO,
Konstantinas Povilas VALUCKAS,
Fluorescence diagnostics of oral cancer
,
Acta medica Lituanica: Vol. 18 No. 2 (2011)
-
Ieva Vincerževskienė,
Agnė Krilavičiūtė,
Giedrė Smailytė,
Trends in cancer incidence in Lithuania between 1991 and 2010
,
Acta medica Lituanica: Vol. 20 No. 4 (2013)
-
Albertas Ulys,
Agnė Ulytė,
Pavel Dziameshka,
Oleg Sukonko,
Sergei Krasny,
Sergei Polyakov,
Giedrė Smailytė,
High-risk prostate cancer: factors predicting biochemical recurrence after radical prostatectomy
,
Acta medica Lituanica: Vol. 22 No. 3 (2015)
-
Daimantas MILONAS,
Giedrė SMAILYTĖ,
Darius TRUMBECKAS,
Mindaugas JIEVALTAS,
Oncological outcomes of surgery in very high risk pT3b prostate cancer
,
Acta medica Lituanica: Vol. 18 No. 3 (2011)
-
Arnoldas Krasauskas,
Renatas Aškinis,
Sigitas Zaremba,
Giedrė Smailytė,
Saulius Cicėnas,
Surgery for lung cancer as the second primary malignancy
,
Acta medica Lituanica: Vol. 19 No. 4 (2012)
-
Giedrė Smailytė,
Robertas Adomaitis,
Karolis Ulinskas,
Birutė Aleknavičienė,
Prostate cancer patient’s survival in Lithuania
,
Acta medica Lituanica: Vol. 19 No. 4 (2012)
-
Robertas ADOMAITIS,
Feliksas JANKEVICIUS,
Giedre SMAILYTE,
Ruta LEVULIENE,
Changes in prostate cancer incidence in 50–75-year-old men in Lithuania 2006–2009: effect of early diagnosis program
,
Acta medica Lituanica: Vol. 18 No. 2 (2011)
-
Giedre SMAILYTE,
Laurynas PAREIGIS,
Time trends in avoidable cancer mortality in Lithuania 1992–2008
,
Acta medica Lituanica: Vol. 18 No. 4 (2011)